Abingworth ^Investors

Abingworth is an international investment group that specializes in collaborating with life sciences entrepreneurs to develop breakthrough medicine. With over $1 billion under management, Abingworth invests in all stages of development and across all life sciences sectors. They have a team of 27 professionals located in London, Menlo Park, and Boston, who support their portfolio companies. Abingworth has invested in 142 life science companies, completed 60 IPOs, and 40 mergers and acquisitions. Since their establishment in 1987, they have gained extensive experience in building successful biopharma companies.